NCT03606421
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have 1-10 lesions confirmed by MRI
Exclusions: Patients with prior radiation therapy for brain tumor(s); Patients who have undergone surgical resection for brain tumor(s); Patients with leptomeningeal metastasis
https://ClinicalTrials.gov/show/NCT03606421